Lakefront Biotherapeutics | GLPG - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
argenx SE USD 426M 22.71M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Biogen USD 377.7M 433.7M 2026-03
Genmab DKK 55M 427M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 112M 78.51M 2026-03
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Incyte USD 343.6M 46.34M 2026-03
Merck EUR 401M 886.1M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03